Literature DB >> 26676097

An AlphaScreen Assay for the Discovery of Synthetic Chemical Inhibitors of Glucagon Production.

Matthew R Evans1, Shuguang Wei1, Bruce A Posner1, Roger H Unger2, Michael G Roth3.   

Abstract

Glucose homeostasis is primarily controlled by two opposing hormones, insulin and glucagon, and diabetes results when insulin fails to inhibit glucagon action. Recent efforts to control glucagon in diabetes have focused on antagonizing the glucagon receptor, which is effective in lowering blood glucose levels but leads to hyperglucogonemia in rodents. An alternative strategy would be to control glucagon production with small molecules. In pursuit of this goal, we developed a homogeneous AlphaScreen assay for measuring glucagon in cell culture media and used this in a high-throughput screen to discover synthetic compounds that inhibited glucagon secretion from an alpha cell-like cell line. Some of these compounds inhibited transcription of the glucagon gene.
© 2015 Society for Laboratory Automation and Screening.

Entities:  

Keywords:  AlphaScreen; competition assay; diabetes; glucagon

Mesh:

Substances:

Year:  2015        PMID: 26676097      PMCID: PMC5226228          DOI: 10.1177/1087057115622201

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  27 in total

1.  Is HbA(1c) affected by glycemic instability?

Authors:  Rachel Derr; Elizabeth Garrett; Gerald A Stacy; Christopher D Saudek
Journal:  Diabetes Care       Date:  2003-10       Impact factor: 19.112

2.  Glucagon antibodies and an immunoassay for glucagon.

Authors:  R H UNGER; A M EISENTRAUT; M S McCALL; L L MADISON
Journal:  J Clin Invest       Date:  1961-07       Impact factor: 14.808

3.  Glucose stimulates glucagon release in single rat alpha-cells by mechanisms that mirror the stimulus-secretion coupling in beta-cells.

Authors:  Hervør Lykke Olsen; Sten Theander; Krister Bokvist; Karsten Buschard; Claes B Wollheim; Jesper Gromada
Journal:  Endocrinology       Date:  2005-08-04       Impact factor: 4.736

4.  Metabolic manifestations of insulin deficiency do not occur without glucagon action.

Authors:  Young Lee; Eric D Berglund; May-yun Wang; Xiaorong Fu; Xinxin Yu; Maureen J Charron; Shawn C Burgess; Roger H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-13       Impact factor: 11.205

5.  Glucagon receptor antibody completely suppresses type 1 diabetes phenotype without insulin by disrupting a novel diabetogenic pathway.

Authors:  May-Yun Wang; Hai Yan; Zhiqing Shi; Matthew R Evans; Xinxin Yu; Young Lee; Shiuhwei Chen; Annie Williams; Jacques Philippe; Michael G Roth; Roger H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-09       Impact factor: 11.205

Review 6.  Pancreatic α-cell hyperplasia: facts and myths.

Authors:  Run Yu
Journal:  J Clin Endocrinol Metab       Date:  2013-11-27       Impact factor: 5.958

7.  Early postprandial glucagon surge affects postprandial glucose levels in obese and non-obese patients with type 2 diabetes.

Authors:  Junji Kozawa; Kohei Okita; Hiromi Iwahashi; Kazuya Yamagata; Akihisa Imagawa; Iichiro Shimomura
Journal:  Endocr J       Date:  2013-03-02       Impact factor: 2.349

8.  Reduction in glucagon receptor expression by an antisense oligonucleotide ameliorates diabetic syndrome in db/db mice.

Authors:  Yin Liang; Melville C Osborne; Brett P Monia; Sanjay Bhanot; William A Gaarde; Chantal Reed; Pengxiang She; Thomas L Jetton; Keith T Demarest
Journal:  Diabetes       Date:  2004-02       Impact factor: 9.461

9.  Systematic identification of molecular subtype-selective vulnerabilities in non-small-cell lung cancer.

Authors:  Hyun Seok Kim; Saurabh Mendiratta; Jiyeon Kim; Chad Victor Pecot; Jill E Larsen; Iryna Zubovych; Bo Yeun Seo; Jimi Kim; Banu Eskiocak; Hannah Chung; Elizabeth McMillan; Sherry Wu; Jef De Brabander; Kakajan Komurov; Jason E Toombs; Shuguang Wei; Michael Peyton; Noelle Williams; Adi F Gazdar; Bruce A Posner; Rolf A Brekken; Anil K Sood; Ralph J Deberardinis; Michael G Roth; John D Minna; Michael A White
Journal:  Cell       Date:  2013-10-24       Impact factor: 41.582

10.  Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.

Authors:  Baozhi Chen; Michael E Dodge; Wei Tang; Jianming Lu; Zhiqiang Ma; Chih-Wei Fan; Shuguang Wei; Wayne Hao; Jessica Kilgore; Noelle S Williams; Michael G Roth; James F Amatruda; Chuo Chen; Lawrence Lum
Journal:  Nat Chem Biol       Date:  2009-01-04       Impact factor: 15.040

View more
  2 in total

1.  Dapagliflozin suppresses glucagon signaling in rodent models of diabetes.

Authors:  May-Yun Wang; Xinxin Yu; Young Lee; Sara Kay McCorkle; Shiuhwei Chen; Jianping Li; Zhao V Wang; Jaime A Davidson; Philipp E Scherer; William L Holland; Roger H Unger; Michael G Roth
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-05       Impact factor: 11.205

2.  Development and Characterization of Quantitative, High-Throughput-Compatible Assays for Proteolytic Degradation of Glucagon.

Authors:  Caitlin N Suire; Shelley Lane; Malcolm A Leissring
Journal:  SLAS Discov       Date:  2018-07-11       Impact factor: 3.341

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.